123 related articles for article (PubMed ID: 26608891)
1. Administration of branched-chain amino acids alters the balance between pro-inflammatory and anti-inflammatory cytokines.
Rosa L; Scaini G; Furlanetto CB; Galant LS; Vuolo F; Dall'Igna DM; Schuck PF; Ferreira GC; Dal-Pizzol F; Streck EL
Int J Dev Neurosci; 2016 Feb; 48():24-30. PubMed ID: 26608891
[TBL] [Abstract][Full Text] [Related]
2. Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats.
Wessler LB; de Miranda Ramos V; Bittencourt Pasquali MA; Fonseca Moreira JC; de Oliveira J; Scaini G; Streck EL
Int J Dev Neurosci; 2019 Nov; 78():210-214. PubMed ID: 31330240
[TBL] [Abstract][Full Text] [Related]
3. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
4. Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.
Rosa L; Galant LS; Dall'Igna DM; Kolling J; Siebert C; Schuck PF; Ferreira GC; Wyse ATS; Dal-Pizzol F; Scaini G; Streck EL
Mol Neurobiol; 2016 Aug; 53(6):3714-3723. PubMed ID: 26133302
[TBL] [Abstract][Full Text] [Related]
5. Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.
Scaini G; Morais MO; Furlanetto CB; Kist LW; Pereira TC; Schuck PF; Ferreira GC; Pasquali MA; Gelain DP; Moreira JC; Bogo MR; Streck EL
Neurochem Res; 2015 May; 40(5):885-93. PubMed ID: 25681161
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
7. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
Scaini G; Teodorak BP; Jeremias IC; Morais MO; Mina F; Dominguini D; Pescador B; Comim CM; Schuck PF; Ferreira GC; Quevedo J; Streck EL
Behav Brain Res; 2012 May; 231(1):92-6. PubMed ID: 22433584
[TBL] [Abstract][Full Text] [Related]
9. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.
Scaini G; Comim CM; Oliveira GM; Pasquali MA; Quevedo J; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Bogo MR; Streck EL
J Inherit Metab Dis; 2013 Sep; 36(5):721-30. PubMed ID: 23109061
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of intracerebroventricular administration of α-ketoisocaproic acid in young rats on inflammatory parameters.
Rabelo F; Lemos IDS; Dal Toé CP; Casagrande DD; Freitas MLS; Quadra MR; Lima IR; Generoso JS; Michels M; Silveira PCL; Pizzol FD; Streck EL
Metab Brain Dis; 2023 Jun; 38(5):1573-1579. PubMed ID: 36897514
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus.
Scaini G; Mello-Santos LM; Furlanetto CB; Jeremias IC; Mina F; Schuck PF; Ferreira GC; Kist LW; Pereira TC; Bogo MR; Streck EL
Mol Neurobiol; 2013 Dec; 48(3):581-9. PubMed ID: 23559405
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.
Scaini G; Morais MO; Galant LS; Vuolo F; Dall'Igna DM; Pasquali MA; Ramos VM; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Soriano FG; Dal-Pizzol F; Streck EL
Mol Neurobiol; 2014 Oct; 50(2):358-67. PubMed ID: 24390570
[TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acids accumulating in maple syrup urine disease induce morphological alterations in C6 glioma cells probably through reactive species.
de Lima Pelaez P; Funchal C; Loureiro SO; Heimfarth L; Zamoner A; Gottfried C; Latini A; Wajner M; Pessoa-Pureur R
Int J Dev Neurosci; 2007 May; 25(3):181-9. PubMed ID: 17317075
[TBL] [Abstract][Full Text] [Related]
15. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
[TBL] [Abstract][Full Text] [Related]
16. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
17. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
[TBL] [Abstract][Full Text] [Related]
18. DNA damage in an animal model of maple syrup urine disease.
Scaini G; Jeremias IC; Morais MO; Borges GD; Munhoz BP; Leffa DD; Andrade VM; Schuck PF; Ferreira GC; Streck EL
Mol Genet Metab; 2012 Jun; 106(2):169-74. PubMed ID: 22560665
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease.
Scaini G; de Rochi N; Jeremias IC; Deroza PF; Zugno AI; Pereira TC; Oliveira GM; Kist LW; Bogo MR; Schuck PF; Ferreira GC; Streck EL
Mol Neurobiol; 2012 Apr; 45(2):279-86. PubMed ID: 22328136
[TBL] [Abstract][Full Text] [Related]
20. A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies.
Bridi R; Fontella FU; Pulrolnik V; Braun CA; Zorzi GK; Coelho D; Wajner M; Vargas CR; Dutra-Filho CS
J Neurosci Methods; 2006 Sep; 155(2):224-30. PubMed ID: 16530844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]